WC
ABBV icon

Westhampton Capital’s AbbVie ABBV Stock Holding History

Westhampton Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Sell
9,800
-34
-0.3% -$7.32K 1.02% 27
2026
Q1 		$2.14M Hold
9,834
– – 1% 29
2025
Q4 		$2.25M Sell
9,834
-100
-1% -$22.8K 1.06% 28
2025
Q3 		$2.3M Sell
9,934
-40
-0.4% -$8.15K 1.12% 26
2025
Q2 		$1.85M Sell
9,974
-200
-2% -$37.2K 0.96% 32
2025
Q1 		$2.13M Hold
10,174
– – 1.16% 25
2024
Q4 		$1.81M Buy
10,174
+1,365
+15% +$251K 0.92% 33
2024
Q3 		$1.74M Hold
8,809
– – 0.88% 39
2024
Q2 		$1.51M Buy
8,809
+1,000
+13% +$166K 0.82% 41
2024
Q1 		$1.42M Sell
7,809
-750
-9% -$129K 0.78% 47
2023
Q4 		$1.33M Sell
8,559
-1,735
-17% -$253K 0.79% 47
2023
Q3 		$1.53M Sell
10,294
-75
-0.7% -$11K 0.99% 36
2023
Q2 		$1.4M Sell
10,369
-65
-0.6% -$9.53K 0.91% 39
2023
Q1 		$1.66M Buy
10,434
+10
+0.1% +$1.53K 1.07% 29
2022
Q4 		$1.68M Buy
10,424
+135
+1% +$20.7K 1.14% 26
2022
Q3 		$1.38M Buy
10,289
+200
+2% +$28.7K 1.04% 30
2022
Q2 		$1.54M Buy
10,089
+40
+0.4% +$6.11K 1.09% 30
2022
Q1 		$1.63M Buy
10,049
+50
+0.5% +$7.26K 1.05% 31
2021
Q4 		$1.35M Sell
9,999
-870
-8% -$103K 0.83% 42
2021
Q3 		$1.17M Buy
10,869
+280
+3% +$32K 0.8% 43
2021
Q2 		$1.19M Buy
10,589
+450
+4% +$50.7K 0.78% 43
2021
Q1 		$1.1M Buy
10,139
+3,975
+64% +$425K 0.76% 42
2020
Q4 		$660K Buy
6,164
+215
+4% +$20.7K 0.49% 58
2020
Q3 		$521K Buy
5,949
+1,024
+21% +$96.4K 0.43% 64
2020
Q2 		$484K Buy
4,925
+655
+15% +$57.7K 0.42% 66
2020
Q1 		$325K Buy
4,270
+1,170
+38% +$99.7K 0.34% 73
2019
Q4 		$274K Hold
3,100
– – 0.22% 94
2019
Q3 		$235K Sell
3,100
-700
-18% -$48K 0.2% 99
2019
Q2 		$276K Buy
+3,800
New +$299K 0.23% 96

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Westhampton Capital's ABBV Position: Q2 2026 in Review

Westhampton Capital reduced its AbbVie (ABBV) stake by 0.35% in Q2 2026, selling an estimated $7.32K and leaving 9,800 shares worth $2.47M. The position accounts for 1.02% of the portfolio, ranked #27.

Westhampton Capital first reported a position in ABBV in Q2 2019 and has held it in 29 quarters since. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Westhampton Capital held 9,800 shares of AbbVie worth $2.47M as of Q2 2026.
  • Westhampton Capital sold 34 AbbVie shares in Q2 2026, an estimated $7.32K.
  • AbbVie made up 1.02% of Westhampton Capital's portfolio in Q2 2026, its #27 holding.
  • Westhampton Capital first reported a position in AbbVie in Q2 2019 and has held it in 29 quarters since.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.